Navigation Links
Penn study finds link between Parkinson's disease genes and manganese poisoning
Date:2/1/2009

PHILADELPHIA A connection between genetic and environmental causes of Parkinson's disease has been discovered by a research team led by Aaron D. Gitler, PhD, Assistant Professor in the Department of Cell and Developmental Biology at the University of Pennsylvania School of Medicine. Gitler and colleagues found a genetic interaction between two Parkinson's disease genes (alpha-synuclein and PARK9) and determined that the PARK9 protein can protect cells from manganese poisoning, which is an environmental risk factor for a Parkinson's disease-like syndrome. The findings appear online this week in Nature Genetics.

Manganism, or manganese poisoning, is prevalent in such occupations as mining, welding, and steel manufacturing. It is caused by exposure to excessive levels of the metal manganese, which attacks the central nervous system, producing motor and dementia symptoms that resemble Parkinson's disease.

In Parkinson's patients, the alpha-synuclein protein normally found in the brain misfolds, forming clumps. Yeast cells, the model system in which Gitler studies disease proteins, also form clumps and die when this protein is expressed at high levels. These are the same yeast cells that bakers and brewers use to make bread, beer, and wine.

As a postdoctoral fellow at the Whitehead Institute in Cambridge, Massachusetts, Gitler and colleagues started looking for genes that could prevent the cell death caused by mis-folded alpha-synuclein in yeast. Eventually they found a few genes to test in animal models and some were able to protect neurons from the toxic effects of alpha-synuclein. "One of the genes that we found was a previously uncharacterized yeast gene called YOR291W. No one knew what it did back in 2006," he recalls.

In the meantime, researchers in Europe published studies about a family that had an early-onset form of a type of Parkinson's disease caused by mutations in the PARK9 gene. "When I read about this study
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

4

GOOD

Page: 1 2 3

Related medicine news :

1. Study suggests that inflammation may be the link between extreme sleep durations and poor health
2. Study finds genetic link between sleep disorders and depression in young children
3. Stanford study prevents pancreatic tumor growth in mice by inhibiting key protein
4. Study of Iraq veterans traumatic brain injuries to be conducted by UB researchers
5. Study confirms persistence of diversity problems in academic medicine
6. Oncogene inhibits tumor suppressor to promote cancer: Study links B-RAF and LKB1
7. Perceptions and experiences of homeless youth vary by race, UCSF study shows
8. New Study: Protein in the Morning Helps Dieters Stay on Track and Keep Weight Off
9. New study explores the relationship between preterm birth and autism spectrum disorder
10. Study finds preemies more likely to score positive
11. Weight loss reduces incontinence in obese women, UCSF study shows

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Penn study finds link between Parkinson's disease genes and manganese poisoning
Penn study finds link between Parkinson's disease genes and manganese poisoning
(Date:11/30/2009)...s in animals , , MONDAY, Nov. 30 (Heal...that stem cells from transplanted human-derived um...heart disorders. , Scientists already know tha...st of different kinds of cells in the laboratory, ... Seoul, Korea, co-author of one of the studies, sa...
(Date:11/30/2009)...wire/ -- Kemin Foods, L.C. ("Kemin") and OmniActiv...Technologies, Ltd. ("OmniActive") have reached an ...agree that Kemin,s US Patent No. 5,382,714 ("the ,...cation and Recrystallization of Lutein from Saponi...reissues of that patent are valid and enforceable....
(Date:11/30/2009)...PRNewswire/ -- During this time of year, people be...oved one with Alzheimer,s disease or other form of...truggle with appropriate gift items. ,, Brookd...f senior living residences in the nation, includin...ggestions. ,, A listening device with recordin...
(Date:11/30/2009)... and Europa Uomo, the European,advocacy movement ...d into an,affiliated partnership as part of their...ient awareness in Europe with regards to urologica...ecretary-General of the EAU: "Thanks to this uniqu...in access to the latest information on,optimum su...
(Date:11/30/2009)...ched a series of clinical trials in order to asses... approach involves the application of personalised...rom the patient him or herself and designed to com...frequent malignant tumours. The new therapy is adm...the standard, first-line treatment involving surgi...
Breaking Medicine News(10 mins):Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6
...y hospital's inability to activate emergency power...ddle of a cataract surgery was awarded over Rs one... "It had taken about 15-20 minutes of crucial ...," observed the Consumer Disputes Redressal Forum ...
..., spread of infectious disease and food security u...ry in order to acquire the proper balance between ...phy professor of Kansas State University has used ...in uses remote sensing, in combination with other ...
...Toronto General Hospital, researchers have discove...ion //of specific repair cells from the bone marro...le it has long been known that bone marrow cells h... stem cells in repairing a damaged heart, restorin...
...a good 14 years has revealed that regular exercise...e body weight has an impact in cutting down the ri...uthor of the study, said "Even though erectile pro...." Obesity also affects sexual health, he said. ...
...f BARACLUDE? (entecavir) for the treatment of chro...proval by the Drug Controller General of India. ...atment of chronic hepatitis B virus infection in a... active disease. BARACLUDE? is an oral antiv...
...management training center, not only training Indi...tries//. The MV Hospital for Diabetes and Diabetes...zation’s collaborating centre for diabetes researc...e center is currently coaching a Pakistani physici...
Other Medicine News:Health News:Ecological Changes affects human health, food security 2Health News:Bone Marrow Cells Aid In Heart Repair 2Health News:Bone Marrow Cells Aid In Heart Repair 3Health News:India Approves Baraclude? (entecavir) For ,Treatment Of Chronic HEPATITIS B 2
(Date:11/30/2009)..., , TORONTO, Nov. 30 The S...on Inc. ("Patheon" or the "Company") (TSX: PTI) an...n Holdings, LLC (collectively, "JLL"), today annou...settlement agreement in respect of the pending leg...ment provides among other things that: ,, unti...
(Date:11/30/2009)..., , SCOTTSDALE, Ariz., Nov. 30 /PRNe... the leading provider of radiology solutions to ra... States, has implemented a redesigned Quality Assu...between NightHawk,s radiologists and customers and...wk will be providing an overview of the new QA pro...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ ...search report is available in its catalogue: ,,..., http://www.reportlinker.com/p0164299/Surgical-I...cal incision closures market holds enormous signif... being performed each year. Surgical disciplines s...
Breaking Medicine Technology:Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 1AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 2AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 3AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 4Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 1Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 2Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 3Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 1Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 2
...ults of Roche and Ipsen,s First Once-Weekly Human ...iation Meeting -, NUTLEY, N.J., June 10 Roche an...poglutide (R1583) has been shown to provide,signif...oss after only,eight weeks of treatment(1,2) with ...try into Phase III. Taspoglutide, originating from...
...estigational Diabetes Therapy Also Improved Glucos... Taken Twice a Day, SAN FRANCISCO, June 9 Amylin...and Company (NYSE: LLY ), and Alkermes, Inc.,(Nas...k open-label clinical,study that showed the durabl... release formulation of exenatide. Patients taking...
Other Medicine Technology:Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 2After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 3After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 4After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 5After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 7After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 8After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 9
Cushing Burr
Doro J-Arm Retractor System
Molt 9
Langenbeck Periosteal Elevators
Medicine Products: